Biotec Pharmacon ASA, together with its subsidiaries, develops, manufactures, and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology in Norway. It is involved in the research on products to prevent or treat diseases caused by failure, imbalance, and over-reaction of the immune system. The company manufactures and sells beta-1,3/1,6-glucan, a non-toxic modulator of various immune functions in the body, and affects various immunity related disorders. It also offers cold adapted and heat labile enzymes with properties for molecular biology research and PCR based diagnostics to international research reagents and diagnostics companies; and beta-glucans. The company was founded in 1990 and is based in Tromsø, Norway.
biotec pharmacon asa (BIOTEC:Oslo)
PO Box 6463
Phone: 47 77 64 89 00
Fax: 47 77 64 89 01www.biotec.no
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for BIOTEC.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact BIOTEC PHARMACON ASA, please visit www.biotec.no. Company data is provided by Capital IQ. Please use this form to report any data issues.